跳至主要内容
临床试验/ITMCTR2000003084
ITMCTR2000003084尚未招募4 期

Real World Study of Ningmitai Capsule in Treating Chronic Prostatitis Symptoms

Peking University First Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

性别
Male

入选标准

  • 1. Chronic prostatitis: Chronic and recurrent pelvic discomfort or pain (NIH-CPSI pain score >= 4) lasting more than 3 months;
  • 2. The patients accepted urine routine, EPS routine and prostate color ultrasound examination and were willing to follow-up on time;
  • 3. According to the 2014 edition of the China Society of Urology's guidelines for the diagnosis and treatment of chronic prostatitis, treatment options are determined by doctors The use of proprietary Chinese medicine according to the Chinese Society of Integrated Traditional Chinese and Western medicine andrology 2015 edition of chronic prostatitis integrated traditional Chinese and Western medicine expert consensus using Ningbitai capsules;
  • 4. Volunteer and agree to sign an informed consent.

排除标准

  • 1. Patients who were involved in other clinical studies;
  • 2. Urine routine or color doppler ultrasound examination of the prostate suggested other organic diseases of the Urinary System;
  • 3. Patients with serious cardiovascular, cerebrovascular, liver, Kidney, hematopoiesis and psychosis;
  • 4. People who are known to be allergic to Ningmitai capsules or some of their ingredients.

研究者

相似试验